
In the present study, we conducted a Phase 1 study of a zzso zzso zzso zzso zzso that has the same zzso acid sequence as zzso The purpose of this study was to evaluate the safety, zzso and potential benefit of zzso in Chinese patients with advanced zzso zzso zzso In this study, 18 patients were treated with two successive treatment schedules zzso a zzso escalation phase followed by a weekly, zzso extension zzso No zzso toxicity was reported during the evaluation zzso zzso toxicity was zzso and the most commonly reported adverse events were fever, zzso zzso zzso zzso and skin zzso zzso exhibited a zzso zzso profile over the dose range of 100 to 400 zzso In the zzso phase, zzso reached peak serum zzso at the end of the infusion and then declined slowly with a zzso of zzso zzso zzso zzso zzso zzso and zzso zzso h after infusion of 100, zzso and 400 zzso ( 2) based on a two zzso model zzso Mean zzso increased roughly zzso while zzso showed a greater than zzso increase from 100 to 400 zzso ( 2) zzso After multiple zzso serum zzso dropped slowly and the zzso was zzso zzso zzso h and zzso zzso zzso h based on a two zzso model zzso No zzso zzso zzso were zzso Two patients achieved partial zzso The study results suggest that zzso shows acceptable tolerance and primary efficacy and should be studied as a treatment in patients with advanced zzso zzso zzso 

